Evidence map›Paper›PMID 37947013›Full record

ReviewESC heart failure2024

Enhancing myocardial function with cardiac contractility modulation: potential and challenges.

Zihan Li, Qiming Liu, Shenghua Zhou, Yichao Xiao

Open access · goldAbstract readReview
In one paragraph

Review in ESC heart failure, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.2field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Molecular Mechanisms of Cardiac Adaptation After Device Deployment.Journal of cardiovascular development and disease · 2025
    Review
  7. Article
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Zihan LiDepartment of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, China.
Qiming LiuDepartment of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, China.
Shenghua ZhouDepartment of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, China.
Yichao XiaoDepartment of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, China.ORCID https://orcid.org/0000-0003-4535-3339
Central South University · CN

Funding

Clinical Medical Technology Innovation Guidance Project of Hunan Science and Technology Agency 2021SK53519
6 · The paper itself

Abstract

Cardiac contractility modulation (CCM) offers a novel therapeutic avenue for heart failure patients, particularly those unresponsive to cardiac resynchronization therapy within specific QRS duration ranges. This review elucidates CCM's mechanistic underpinnings, its impact on myocardial function, and utility across patient demographics. However, CCM is limited by insufficient data on mortality and hospitalization rate reductions, as well as the need for specialized device implantation skills. While prevailing research has concentrated on left ventricular effects, a knowledge gap persists for other patient subsets. Future inquiries should address combinatory treatment strategies, extended usage and the impact of atrial fibrillation on device implantation. Such expanded studies could refine therapeutic outcomes and widen the scope of beneficiaries.

Indexed as

Atrial FibrillationCardiac Resynchronization TherapyHeart FailureHumansMyocardial ContractionMyocardiumCardiac contractility modulationCardiac devicesDevice implantationHeart failure

Identifiers

PMID37947013
PMCPMC10804199
OpenAlexW4388572836

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.